An independent analysis of ~ 4500 primary breast cancers showed no prognostic value for RANK/RANKL expression, but a substantially better prognosis in oestrogen receptor-positive breast cancer cases showing high OPG expression (Sanger et al., 2014). This evidence concerns the gene TNFRSF11A and breast cancer.